6-[(3-Fluorophenyl)methyl]-5,7-dimethyl-2-(methylsulfanyl)-[1,2,4]triazolo[1,5-a]pyrimidine

Catalog No. :
ACGFEN822
CAS No. :
439111-27-0
Molecular Formula :
C15H15FN4S
Molecular Weight :
302.38

IUPAC Name:6-(3-fluorobenzyl)-5,7-dimethyl-2-(methylthio)-[1,2,4]triazolo[1,5-a]pyrimidine

6-[(3-Fluorophenyl)methyl]-5,7-dimethyl-2-(methylsulfanyl)-[1,2,4]triazolo[1,5-a]pyrimidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg90%$128.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name6-[(3-Fluorophenyl)methyl]-5,7-dimethyl-2-(methylsulfanyl)-[1,2,4]triazolo[1,5-a]pyrimidine
IUPAC Name6-(3-fluorobenzyl)-5,7-dimethyl-2-(methylthio)-[1,2,4]triazolo[1,5-a]pyrimidine
Molecular FormulaC15H15FN4S
Molecular Weight302.38
SMILESCSC1=NN2C(C)=C(CC3=CC=CC(F)=C3)C(C)=NC2=N1
InChI KeyXEEHUINLYRROBE-UHFFFAOYSA-N
Synonym6-[(3-fluorophenyl)methyl]-5,7-dimethyl-2-(methylsulfanyl)-[1,2,4]triazolo[1,5-a]pyrimidine;6-(3-FLUOROBENZYL)-5,7-DIMETHYL[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-2-YL METHYL SULFIDE;6-(3-FLUOROBENZYL)-5,7-DIMETHYL-2-(METHYLSULFANYL)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDINE;[1,2,4]Triazolo[1,5-a]pyrimidine, 6-[(3-fluorophenyl)methyl]-5,7-dimethyl-2-(methylthio)-
CAS No.439111-27-0

Synthetic Route by SureRoute

1. ACGFEN822 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGFEN822 route product structure diagram
    ACGFEN822439111-27-0
Inquiry

2. ACGFEN822 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACRPFW239 route compound structure diagram
    ACRPFW23945534-08-5 In Stock
  4. Then
  5. ACGFEN822 route product structure diagram
    ACGFEN822439111-27-0
Inquiry

Comments (0)